BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17690908)

  • 1. Possible prognostic role of IL-17R in osteosarcoma.
    Honorati MC; Cattini L; Facchini A
    J Cancer Res Clin Oncol; 2007 Dec; 133(12):1017-21. PubMed ID: 17690908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-17A/IL-17RA interaction promoted metastasis of osteosarcoma cells.
    Wang M; Wang L; Ren T; Xu L; Wen Z
    Cancer Biol Ther; 2013 Feb; 14(2):155-63. PubMed ID: 23192273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-6 induces vascular endothelial growth factor expression and promotes angiogenesis through apoptosis signal-regulating kinase 1 in human osteosarcoma.
    Tzeng HE; Tsai CH; Chang ZL; Su CM; Wang SW; Hwang WL; Tang CH
    Biochem Pharmacol; 2013 Feb; 85(4):531-40. PubMed ID: 23219526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma.
    Su Y; Wagner ER; Luo Q; Huang J; Chen L; He BC; Zuo GW; Shi Q; Zhang BQ; Zhu G; Bi Y; Luo J; Luo X; Kim SH; Shen J; Rastegar F; Huang E; Gao Y; Gao JL; Yang K; Wietholt C; Li M; Qin J; Haydon RC; He TC; Luu HH
    Oncogene; 2011 Sep; 30(37):3907-17. PubMed ID: 21460855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. XB130 expression in human osteosarcoma: a clinical and experimental study.
    Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W
    Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible contribution of aminopeptidase N (APN/CD13) to invasive potential enhanced by interleukin-6 and soluble interleukin-6 receptor in human osteosarcoma cell lines.
    Kido A; Krueger S; Haeckel C; Roessner A
    Clin Exp Metastasis; 1999; 17(10):857-63. PubMed ID: 11089884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas.
    Park HR; Min K; Kim HS; Jung WW; Park YK
    Pathol Res Pract; 2008; 204(8):575-82. PubMed ID: 18440723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CUL4A expression in pediatric osteosarcoma tissues and its effect on cell growth in osteosarcoma cells.
    Li X; Xu R; Liu H; Fang K
    Tumour Biol; 2016 Jun; 37(6):8139-44. PubMed ID: 26715273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of vascular endothelial growth factor expression on pathological characteristics and prognosis of osteosarcoma.
    Han G; Wang Y; Bi W; Jia J; Wang W; Xu M
    Clin Exp Med; 2016 Nov; 16(4):577-584. PubMed ID: 26319790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-17 enhances the susceptibility of U-2 OS osteosarcoma cells to NK cell lysis.
    Honorati MC; Neri S; Cattini L; Facchini A
    Clin Exp Immunol; 2003 Sep; 133(3):344-9. PubMed ID: 12930359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
    Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
    J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinases participate in osteosarcoma invasion.
    Bjørnland K; Flatmark K; Pettersen S; Aaasen AO; Fodstad O; Maelandsmo GM
    J Surg Res; 2005 Aug; 127(2):151-6. PubMed ID: 16083752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A humanized bone microenvironment uncovers HIF2 alpha as a latent marker for osteosarcoma.
    Wagner F; Holzapfel BM; Martine LC; McGovern J; Lahr CA; Boxberg M; Prodinger PM; Grässel S; Loessner D; Hutmacher DW
    Acta Biomater; 2019 Apr; 89():372-381. PubMed ID: 30836200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem Cells.
    Di Fiore R; Drago-Ferrante R; Pentimalli F; Di Marzo D; Forte IM; Carlisi D; De Blasio A; Tesoriere G; Giordano A; Vento R
    J Cell Physiol; 2016 Aug; 231(8):1832-41. PubMed ID: 26679758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NKD2, a negative regulator of Wnt signaling, suppresses tumor growth and metastasis in osteosarcoma.
    Zhao S; Kurenbekova L; Gao Y; Roos A; Creighton CJ; Rao P; Hicks J; Man TK; Lau C; Brown AM; Jones SN; Lazar AJ; Ingram D; Lev D; Donehower LA; Yustein JT
    Oncogene; 2015 Sep; 34(39):5069-79. PubMed ID: 25579177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Expression of XRCC6 Promotes Human Osteosarcoma Cell Proliferation through the β-Catenin/Wnt Signaling Pathway and Is Associated with Poor Prognosis.
    Zhu B; Cheng D; Li S; Zhou S; Yang Q
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27455247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TSSC3 overexpression reduces stemness and induces apoptosis of osteosarcoma tumor-initiating cells.
    Huang Y; Dai H; Guo QN
    Apoptosis; 2012 Aug; 17(8):749-61. PubMed ID: 22610481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-17 receptor expression on vascular endothelial cells of masses of skeletal extramedullary disease in myeloma patients.
    Yang JZ; Li Y; Sun LX; Fang J; Kong LJ; Zhang JQ
    Pathol Res Pract; 2014 Sep; 210(9):586-90. PubMed ID: 24916639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined administration of EGCG and IL-1 receptor antagonist efficiently downregulates IL-1-induced tumorigenic factors in U-2 OS human osteosarcoma cells.
    Hönicke AS; Ender SA; Radons J
    Int J Oncol; 2012 Aug; 41(2):753-8. PubMed ID: 22641358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of bone morphogenetic proteins by osteoinductive and non-osteoinductive human osteosarcoma cells.
    Raval P; Hsu HH; Schneider DJ; Sarras MP; Masuhara K; Bonewald LF; Anderson HC
    J Dent Res; 1996 Jul; 75(7):1518-23. PubMed ID: 8876605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.